These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3665580)

  • 1. Alternative pathway complement activation induces reductions in effective hepatic blood flow.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Curr Surg; 1987; 44(4):304-8. PubMed ID: 3665580
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the alternative complement pathway by intraocular lenses.
    Mondino BJ; Nagata S; Glovsky MM
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):905-8. PubMed ID: 4008203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of zymosan activated blood plasma (products of the activation of complement system) on heart function].
    Shebeko VI; Solodkov AP; Rodionov IuIa
    Dokl Akad Nauk SSSR; 1989; 309(3):753-6. PubMed ID: 2630250
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement activation in peritonitis. Association with hepatic and renal perfusion abnormalities. First place winner: Conrad Jobst award.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Am Surg; 1987 Dec; 53(12):683-7. PubMed ID: 3425993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydralazine on liver blood flow in normovolemic dogs.
    Saretok T; Almersjö O; Biber B; Gustavsson B; Hasselgren PO
    Acta Chir Scand; 1984; 150(1):1-4. PubMed ID: 6702386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of x-ray contrast substances on the complement system of rats].
    Sergeev PV; Kul'berg AIa; Shimanovskiĭ NL; Napolov IuK; Ukhanov SV
    Biull Eksp Biol Med; 1989 Jun; 107(6):716-8. PubMed ID: 2790171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
    Kaneko I; Fearon DT; Austen KF
    J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of different lectins on the activity of the alternate pathway of complement].
    Martín-Calama Valero J; Batlle Fonrodona FJ; Prieto Juanin MJ; Vicente García V; López Fernández MF; López Borrasca A
    Sangre (Barc); 1982; 27(3):337-48. PubMed ID: 6818695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
    [No Abstract]   [Full Text] [Related]  

  • 13. Opsonizing and bactericidal effects of piglet complement and their alterations during the biosynthesis of lipopolysaccharide (LPS).
    Dlabac V; Simecková J
    Folia Biol (Praha); 1979; 25(6):417-8. PubMed ID: 391600
    [No Abstract]   [Full Text] [Related]  

  • 14. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 15. [The complement-activating action of modern x-ray contrast agents].
    Napolov IuK; Bolotova EN; Shimanovskiĭ NL
    Eksp Klin Farmakol; 1998; 61(2):60-4. PubMed ID: 9621179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemodynamic effects of zymosan in the perfused rat liver.
    Derbocio AM; Kelmer-Bracht AM; Bracht L; Bracht A; Ishii-Iwamoto EL
    Vascul Pharmacol; 2005 Jun; 43(1):75-85. PubMed ID: 15927539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic complement activation produces hemodynamic changes characteristic of sepsis.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Arch Surg; 1988 Mar; 123(3):316-21. PubMed ID: 3341912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement activation after circulatory collapse with intravenous administration of alphaxolone/alphadolone (Althesin)].
    Olesen AS; Hüttel MS; Hansen SE
    Ugeskr Laeger; 1980 May; 142(21):1359-60. PubMed ID: 7404735
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175.
    Miyamoto Y; Hirose H; Matsuda H; Nakano S; Ohtani M; Kaneko M; Nishigaki K; Nomura F; Kitamura H; Kawashima Y
    Trans Am Soc Artif Intern Organs; 1985; 31():508-11. PubMed ID: 3837498
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose dopamine improves effective hepatic blood flow in murine peritonitis.
    Townsend MC; Schirmer WJ; Schirmer JM; Fry DE
    Circ Shock; 1987; 21(2):149-53. PubMed ID: 3829329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.